Atea Pharmaceuticals GAAP EPS of -$0.57 misses by $0.04
Source: SeekingAlpha
2026-03-05 16:25:22 ET
More on Atea Pharmaceuticals
- Atea Pharmaceuticals, Inc. (AVIR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Atea Pharmaceuticals, Inc. (AVIR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Atea Pharmaceuticals: Potential Best-In-Class HCV Cure With Pivotal Readouts In 2026
- Seeking Alpha’s Quant Rating on Atea Pharmaceuticals
- Historical earnings data for Atea Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Atea Pharmaceuticals GAAP EPS of -$0.57 misses by $0.04
Atea Pharmaceuticals Inc.
NASDAQ: AVIR
AVIR Trading
-3.15% G/L:
$6.08 Last:
298,686 Volume:
$6 Open:
AVIR Latest News
March 05, 2026 04:05:00 pm
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
AVIR Stock Data
$327,351,275
63,985,846
0.97%
32
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
